People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Helix Therapeutics, Inc. | — | Biotechnology | Seed | $2.8M | $111.0M | 2009 |
Peter Glazer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Glazer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Shannon | 1 | 9 |
| Kevin Rakin | 1 | 7 |
| Russell Tweeddale | 1 | 4 |
| Joseph Catino | 1 | 2 |
| Ranjit Bindra | 1 | 1 |
| Gerald Vovis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.